Found 11 matching trials
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE2Neoadjuvant chemotherapy plus toripalimab in patients with locoregionally a...
Status
Active Not Recruiting
Location
Zhejiang Cancer Hospital
Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects
PHASE2This is a pre-surgical study involving subjects with local advanced bladder...
Location
Zhujiang Hospital
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC
PHASE2The purpose of this Phase II, open-label, multicenter, randomized controlle...
Location
Peking University Third Hospital
A Phase Ⅱ Trial of Neoadjuvant Toripalimab Plus Platinum-doublet Chemotherapy in Locally Advanced NSCLC.
PHASE2This is a Phase 2, prospective, single-arm, open-Label, single-center study...
Location
Beijing Cancer Hospital
Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma
PHASE2This is a multicenter, open-label, randomized phase II clinical trial desig...
Location
Multiple Locations
Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC
PHASE3This is a randomized clinical trial comparing neoadjuvant and adjuvant PD-1...
Location
Fujian Cancer Hospital
Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma
PHASE2Few previous studies focused on the neoadjuvant treatments of upper urinary...
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC
PHASE2This is a multicenter, randomized controlled clinical trial (HOPE-07) desig...
Location
Multiple Locations
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3The main questions it aims to answer are:
1. Does the combination of GP in...
Status
Active Not Recruiting
Location
Fujian Cancer Hospital
GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.
PHASE3The investigators have designed a multicenter, open-label, randomized contr...
Location
Sun yat-sen university cancer center